On April 2nd, 2026, the New York Times published a profile of Matthew Gallagher, a 41-year-old entrepreneur from Los Angeles who used AI tools and $20,000 to build Medvi a GLP-1 telehealth provider into what he claims is a $1.8 billion company
Latest Case Studies What People Say About Us Clients trust our quality, reliability, and professionalism, consistently recognizing our commitment to precision, transparency, and high standards across all products
This shift favors the sympathetic ("fight or flight") response, which naturally suppresses saliva production
Starting from the crude biological recombinant product, nearly homogeneous proteins with levels of purity ranging from 9099% can be routinely produced
If youre interested in longevity supplements, Nicotinamide Adenine Dinucleotide (NAD+) is also available, with the same simple, streamlined process